Deals
Bain Weighs $2 Billion Stake Sale in Botox Maker Hugel
- Buyout firm is looking to sell its 44.4% stake in Hugel
- Bain is working with Bank of America on potential deal
This article is for subscribers only.
Bain Capital is considering a sale of its controlling stake in Seoul-listed botox maker Hugel Inc., according to people familiar with the matter.
The buyout firm is seeking as much as $2 billion from a disposal of its 44.4% stake in Hugel, said the people, who asked not to be identified as the information is private. Bain’s holding in the botox maker is valued at about 1.2 trillion won ($1 billion) based on Thursday’s share price.